Enovis (ENOV) | Stock Overview & Key Data
Enovis Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $129.72 on June 9, 2014
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Enovis
ENOV
|
1.31B Small-cap | -11.40% | -13.63% | -9.61% | -20.95% | -20.86% | -31.66% | -63.77% | -70.90% | -55.34% | -45.40% | -38.21% |
| 160.70B Large-cap | -2.02% | 4.97% | -19.35% | -30.98% | -28.60% | -34.98% | -16.97% | -20.08% | 135.84% | 255.56% | 329.52% | |
|
Stryker
SYK
|
126.25B Large-cap | 2.13% | 0.38% | -11.91% | -13.33% | -11.56% | -17.25% | 6.06% | 22.47% | 172.95% | 440.98% | 592.85% |
|
Axogen
AXGN
|
1.94B Small-cap | 5.50% | 6.71% | 33.19% | 46.88% | 41.10% | 341.03% | 367.90% | 106.53% | 628.81% | 1,769.57% | 12,185.71% |
|
Establishment Labs
ESTA
|
1.91B Small-cap | 12.52% | 28.06% | 32.66% | 16.91% | 22.33% | 119.39% | 25.90% | 5.07% | 211.25% | 211.25% | 211.25% |
|
Artivion
AORT
|
1.83B Small-cap | 3.33% | -7.47% | -43.66% | -53.56% | -52.61% | -28.85% | 25.55% | -29.37% | 70.34% | 288.03% | 318.75% |
Ownership & Short Interest
Calculate Your Enovis Investment Returns
Long-Term Investment Performance Analysis
Enovis stock price in Jul 2016 was $49.09, A $1,000.00 lump sum investment in Enovis made 9 years ago would be worth approximately $427.38 today, representing a negative return of -57.26%. This translates to an annualized return (CAGR) of -8.22%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ENOV's 52-week high and low?
- In the last 52 weeks, Enovis reached a high of $36.82 (on July 10, 2025) and a low of $20.55 (on N/A).
- What is the market cap and P/E ratio for ENOV?
- Curious about Enovis's size and valuation? Its market capitalization stands at 1.31B. When it comes to valuation, the P/E ratio (trailing twelve months) is -1.10, and the forward P/E (looking ahead) is 5.94.
- Does ENOV pay dividends? If so, what's the yield?
- As for dividends, Enovis isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Enovis's main competitors or similar companies to consider before investing?
When looking at Enovis, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT160.70B Healthcare Medical Devices -34.98% -16.97% Stryker
SYK126.25B Healthcare Medical Devices -17.25% 6.06% Axogen
AXGN1.94B Healthcare Medical Devices 341.03% 367.90% Establishment Labs
ESTA1.91B Healthcare Medical Devices 119.39% 25.90% Artivion
AORT1.83B Healthcare Medical Devices -28.85% 25.55% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Enovis Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Enovis's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -58.27%, the Debt to Equity ratio from the most recent quarter is 92.47, and its Gross Profit Margin stands at 60.69%.
- What is the recent revenue and earnings growth for ENOV?
- Looking at Enovis's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 2.60%, and quarterly earnings saw a YoY growth of 2.64%.
- How much of ENOV stock is held by insiders and institutions?
- Wondering who owns Enovis stock? Company insiders (like executives and directors) hold about 1.48% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 117.25%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.